Informing women about overdiagnosis in breast cancer screening

This is a randomised trial with longitudinal quantitative and qualitative follow-up, examining how information on overdiagnosis influences women’s decision making about breast cancer screening.

Led by: Dr Jolyn Hersch

Related publications

Previous
Previous

Health-literate action plan studies

Next
Next

Low risk cancer communication